Trulieve Cannabis (TCNNF) Cash & Current Investments (2020 - 2026)
Trulieve Cannabis (TCNNF) recorded quarterly Cash & Current Investments of $352.9 million in Q1 2026, up 38.09% quarter-over-quarter from $255.5 million in Q4 2025, and up 7.44% on a YoY basis from $328.5 million in Q1 2025.
Trulieve Cannabis (TCNNF) Cash & Current Investments (2020 - 2026) Analysis & Trends
Trulieve Cannabis' Cash & Current Investments history runs 7 years deep, the most recent figure standing at $352.9 million for Q1 2026.
- In Q1 2026, Cash & Current Investments rose 7.44% year-over-year to $352.9 million; the TTM figure through Mar 2026 stood at $352.9 million (up 7.44% YoY), while the FY2025 annual figure was $255.5 million, down 14.59% from the prior year.
- Cash & Current Investments was $352.9 million for Q1 2026 at Trulieve Cannabis, up from $255.5 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $450.1 million in Q3 2025 to a low of $14.9 million in Q2 2022.
- Historically, Cash & Current Investments has averaged $255.5 million across 5 years, with a median of $255.5 million in 2025.
- The sharpest annual moves came in 2022 and 2023: Cash & Current Investments sank 94.86% in 2022, then soared 923.92% in 2023.
- A 5-year view of Cash & Current Investments shows it stood at $221.7 million in 2022, then decreased by 6.19% to $208.0 million in 2023, then soared by 43.86% to $299.2 million in 2024, then dropped by 14.59% to $255.5 million in 2025, then surged by 38.09% to $352.9 million in 2026.
- The last three Cash & Current Investments figures came in at $352.9 million (Q1 2026), $255.5 million (Q4 2025), and $450.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 2.15 Bn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 77.77 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.32 Bn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 511.86 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 498.58 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 750.88 Mn |
| 10 | Trulieve Cannabis | - | - | 170.08 Mn | 352.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 352.88 Mn |
| Dec 31, 2025 | 255.54 Mn |
| Sep 30, 2025 | 450.11 Mn |
| Jun 30, 2025 | 392.58 Mn |
| Mar 31, 2025 | 328.45 Mn |
| Dec 31, 2024 | 299.20 Mn |
| Sep 30, 2024 | 238.57 Mn |
| Jun 30, 2024 | 355.18 Mn |
| Mar 31, 2024 | 320.31 Mn |
| Dec 31, 2023 | 207.98 Mn |
| Sep 30, 2023 | 192.16 Mn |
| Jun 30, 2023 | 152.37 Mn |
| Mar 31, 2023 | 185.64 Mn |
| Dec 31, 2022 | 221.71 Mn |
| Sep 30, 2022 | 100.66 Mn |
| Jun 30, 2022 | 14.88 Mn |
| Mar 31, 2022 | 275.86 Mn |
| Dec 31, 2021 | 235.35 Mn |
| Sep 30, 2021 | 213.57 Mn |
| Jun 30, 2021 | 289.24 Mn |